Sanyal et al. evaluated the ALT level in twenty non-diabetic NAFLD patients who were assigned to vitamin E (400 IU/ day) alone or the combination of vitamin E (400 IU/ day) and pioglitazone (30 mg/day) (14). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.